Petmed Express - Internet Versender von Tierarzneimitteln - 500 Beiträge pro Seite

[R-BgO]

Press Release Source: PetMed Express, Inc. On Monday July 19, 2010, 8:00 am

POMPANO BEACH, Fla., July 19, 2010 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (Nasdaq:PETS - News) today announced its financial results for the quarter ended June 30, 2010. Net sales for the quarter ended June 30, 2010 were $74.4 million, compared to $77.2 million for the quarter ended June 30, 2009, a decrease of 3.6%. Net income was $7.2 million, or $0.32 diluted per share, for the quarter ended June 30, 2010, compared to net income of $8.1 million, or $0.36 diluted per share, for the quarter ended June 30, 2009, an 11% decrease to EPS. Reorder sales increased by 7%, from $54.0 million to $57.6 million for the quarters ended June 30, 2009 and 2010, respectively.

Menderes Akdag, CEO and President, commented: "It has been a challenging quarter due to a reduction in our advertising exposure, which is attributed to the lack of availability of television remnant space at affordable prices, combined with consumers giving greater consideration to price and reducing their usage. Our online sales increased by 1% to $52.3 million for the quarter, compared to $51.8 million for the prior quarter, with approximately 70% of our orders being generated from our website during the quarter compared to 67% in the prior quarter. We continued leveraging our operating expenses, which as a percent of sales improved 91 basis points compared to the same quarter in the prior year. Our focus in fiscal 2011 is conversion optimization, and the expansion of our product offerings into pet supplies."

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter's financial results. To access the call, which is open to the public, please dial [phone] (toll free) or [phone]. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on July 19, 2010 until August 2, 2010 at 11:59 P.M. To access the replay, call [phone] (toll free) or [phone], and enter passcode 5500.

[R-BgO]

Today's Buy Opportunity: PetMed Express

By Bryan Hinmon | More Articles
July 30, 2010 | Comments (3)


Welcome to "11 O'Clock Stock." Check back to Fool.com at 11 a.m. ET, and we'll be finding a new great stock every weekday for 50 days. Better yet, we’re so confident in the picks that we’re investing $50,000 of the Fool’s own money in them! To hear more about the series, click here to see a video from Motley Fool co-founder Tom Gardner. Can't make it at 11 a.m. ET? Come back to Fool.com, and we'll have the article in our Top Stories section 24 hours a day.

We all know that man's best friend is a canine -- but could Fido be man's best financial advisor, too? Well, probably not, but your furry pal can lead you to superior investment ideas. So sit ... stay ... and read on to find out why Fido and I think PetMed Express (Nasdaq: PETS) is better than a bowl full of Milk-Bones and Snausages.


We love our pets
The numbers are big:

* 71 million U.S. households own a pet.
* 62% of all U.S. households own a pet.
* We spent $45.5 billion on our pets in 2009 and will spend $47.7 billion this year.

To put that in perspective, Americans will spend as much on pets in 2010 as the Dominican Republic will produce as a country. If Fidoland were a country, it would have the 74th largest gross domestic product, ahead of countries like Costa Rica and Jamaica (combined). With all silly comparisons aside, the point is that the pet market is bigger than Clifford and a potential gold mine for investors.

PetMed Express fills the prescription
Of the $47.7 billion spent on pets last year, $3.7 billion went toward medication. Ten years ago, this market was a near monopoly controlled by veterinarians. The model was simple: When you took Fido for a checkup, your vet would write a prescription and fill it right there. As a pet owner, you were a price taker because you didn't have any other way to fill the prescription.

Enter PetMed Express. The company operates an online and mail order pet pharmacy. Through its website, catalog, and unforgettable phone number (1-800-PetMeds), PetMed Express sells prescription and nonprescription pet medications, generally at prices well below what your vet charges. Typical of an online retailer, the benefit offered to customers is cost savings and the convenience of anytime ordering and home delivery. But PetMed Express goes even further -- it reminds you when Fido is running out of medicine and will call the vet for you to refill the prescription.

Pet owners have embraced and come to love the service PetMed Express offers. Sales, profits, free cash flow, and customer growth have been impressive over the years. Importantly, the company appears to be keeping existing customers happy (reorders make up 75% of sales) while focusing on attracting new customers and growing the business.

Way back in 1996 PetMed began its quest to bust the vet monopoly. It took awhile to gain some traction, but the company now has 6% market share and getting larger. It dominates the mail order business -- all of its competitors only control 5% of the market. That's right, PETS is larger than all of its mail order competitors combined.

Beware the dog catcher
Let's not confuse a Chihuahua for a mastiff, though; vets still control 72% of the pet medication market. And since PetMed Express has generated a return on equity above 30% for each of the past nine years we shouldn't be surprised if competitors come around and start sniffing under its tail. Major sellers of nonprescription meds and other pet supplies, such as PetSmart (Nasdaq: PETM), Wal-Mart (NYSE: WMT), and Amazon.com (Nasdaq: AMZN), are already competing with PetMed Express. However, PETS has the advantage of being a licensed pharmacy in all 50 states, which allows it to deal in prescription medications, where these others can't. The extra regulation that comes with being a pharmacy, combined with the 1-800-PetMeds brand and high customer satisfaction has built the company a competitive advantage. It is why PetMed is so much larger than its nearest direct competitor, Drs. Foster & Smith, and why I think it will be able to defend its niche against the big dogs.

Many investors disagree with this assessment; Shares of PetMed Express are heavily shorted. Even so, the company has the ability and wherewithal to back up its bark. With no debt, a long-tenured management team and a rabid customer base, The Motley Fool is ready to lift its leg and mark its territory by placing real cash behind PetMed Express. Check back to see how PETS and the other stocks in our "11 O'Clock Stock" campaign are faring.

[R-BgO]

http://seekingalpha.com/article/218785-petmed-express-why-we…

[R-BgO]

On Monday October 18, 2010, 9:29 am

POMPANO BEACH, Fla. (AP) -- PetMed Express Inc.'s fiscal second-quarter net income fell 21 percent, stung by higher operating expenses and lower sales.

Shares of the pet medication provider slipped $1.51, or 9.5 percent, to $14.45 in premarket trading on Monday.

President and CEO Menderes Akdag said in a statement that the company, based in Pompano Beach, Fla., spent more to advertise and saw consumers use fewer of its products during the quarter -- as they kept a close eye on prices.

Shoppers have continued to tighten their spending as the unemployment rate remains high and uneasiness over the economy remains.

PetMed Express offers prescription and non-prescription pet medications and other health products for dogs, cats and horses through 1-800-PetMeds and its website. Akdag said online sales increased 4 percent from the prior quarter. The company now gets 72 percent of orders from its website, up from 67 percent in the previous quarter.

PetMed's earnings for the quarter ended Sept. 30 dropped to $5 million, or 22 cents per share, compared with $6.3 million, or 28 cents per share, a year earlier.

The performance fell short of the 26 cents per share that analysts surveyed by Thomson Reuters predicted. These estimates usually take out one-time items.

Operating expenses rose to $14.6 million from $13.9 million.

Revenue for the three months dipped 2 percent to $61.2 million from $62.4 million, missing Wall Street's $62.9 million.

[R-BgO]

Webseite ist aktuell nicht erreichbar...?

[R-BgO]

inzwischen immerhin 3,8% Div-Rendite...:

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES ITS FINANCIAL RESULTS FOR FISCAL 2011

Pompano Beach, Florida, May 9, 2011 -

PetMed Express, Inc. (NASDAQ: PETS) today announced its financial
results for the fiscal year ended March 31, 2011. Net sales for the year ended March 31, 2011 were $231.6
million, compared to $238.3 million for the year ended March 31, 2010, a decrease of 2.8%. For the quarter
ended March 31, 2011, net sales were $50.9 million, compared to $50.3 million for the quarter ended March 31,
2010, an increase of 1.2%. Net income was $20.9 million, or $0.92 diluted per share, for the year ended March
31, 2011, compared to net income of $26.0 million, or $1.14 diluted per share, for the year ended March 31, 2010,
a decrease to earnings per share of 19%.

Net income for the quarter ended March 31, 2011 was $4.1 million, or
$0.19 diluted per share, compared to net income of $6.1 million, or $0.27 diluted per share, for the same quarter
the prior year, a decrease to earnings per share of 30%. Reorder sales for the year ended March 31, 2011 were
$184.3 million, compared to $177.8 million for the year ended March 31, 2010, an increase of 3.7%. Reorder sales
for the quarter ended March 31, 2011 were $41.5 million, compared to $40.4 million for the quarter ended March
31, 2010, an increase of 2.7%. The Company acquired approximately 645,000 new customers during fiscal 2011
compared to 815,000 during fiscal 2010, and for the quarter ended March 31, 2011, the Company acquired
approximately 130,000 customers compared to 134,000 for the quarter ended March 31, 2010.


Menderes Akdag, President and CEO, commented: “It has been a challenging year, which can be attributed to
increased customer acquisition costs and decreased new order sales due to increased competition, along with
consumers giving greater consideration to price and a softer demand for some of the product categories we offer.

To address the decline in sales we implemented a more aggressive pricing strategy combined with increased
advertising, while continuing to expand our product offerings into pet supplies. Our cash flows from operations
increased to $30.1 million for the year ended March 31, 2011 from $27.7 million for the prior fiscal year.

During the
quarter we bought back approximately 465,000 shares of our common stock for $7.0 million, and for the fiscal year
we bought back approximately 791,000 shares of our common stock for $12.2 million. During the fiscal year, we
increased our quarterly dividends to $0.125 per share, an increase of 25% from the prior year.”

[R-BgO]

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES ITS FIRST QUARTER FINANCIAL RESULTS

Pompano Beach, Florida, July 18, 2011 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended June 30, 2011. Net sales for the quarter ended June 30, 2011 were $73.6 million, compared to $74.4 million for the quarter ended June 30, 2010, a decrease of 1.1%. Net income was $4.8 million, or $0.22 diluted per share, for the quarter ended June 30, 2011, compared to net income of $7.2 million, or $0.32 diluted per share, for the quarter ended June 30, 2010, a 30% decrease to EPS. New order sales increased by 1.3%, from $16.7 million to $17.0 million for the quarters ended June 30, 2010 and 2011, respectively. The Company acquired approximately 226,000 new customers for the quarter ended June 30, 2011, compared to 220,000 new customers for the quarter ended June 30, 2010.

Menderes Akdag, CEO and President, commented: “Although our sales were slightly down due to our more aggressive flea & tick product pricing, we had a slight increase in orders, which was a positive. Additionally, our online sales increased by 3.4% to $54.1 million for the quarter, compared to $52.3 million for the quarter the prior year, with approximately 73% of our orders being generated from our website during the quarter compared to 70% for the quarter the prior year. During the quarter we bought back approximately 1.1 million shares of our common stock for $13.6 million, an average price of $12.67 per share.”

[R-BgO]

Kurs hat sich leider schon vorher sehr erholt...:


PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES THIRD QUARTER FINANCIAL RESULTS

Net Sales Increased 12% to $50.5 Million
New Order Sales Increased 29% to $10.1 Million
Online Sales Increased 19% to $38.7 Million

Pompano Beach, Florida, January 23, 2012 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended December 31, 2011. Net sales for the quarter ended December 31, 2011 were $50.5 million, compared to $45.1 million for the quarter ended December 31, 2010, an increase of 12%. Net sales for the nine months ended December 31, 2011 were $182.3 million, compared to $180.7 million for the nine months ended December 31, 2010, an increase of 1%. Net income was $3.9 million or $0.19 diluted per share for the quarter ended December 31, 2011, compared to net income of $4.5 million or $0.20 diluted per share for the quarter ended December 31, 2010, a 3% decrease to EPS. For the nine months ended December 31, 2011, net income was $12.7 million or $0.61 diluted per share, compared to net income of $16.7 million or $0.74 diluted per share for the nine months ended December 31, 2010, a decrease to earnings per share of 17%. New order sales increased by 29%, from $7.8 million to $10.1 million for the quarters ended December 31, 2010 and 2011, respectively. New order sales for the nine months ended December 31, 2011 were $39.8 million, compared to $37.9 million for the nine months ended December 31, 2010, an increase of 5%.

Menderes Akdag, President and CEO, commented: "We are pleased to report that we acquired 150,000 new customers in the quarter ended December 31, 2011, compared to 111,000 new customers acquired for the same period in the prior year, a 35% increase. Our advertising cost to acquire a new customer decreased by 11% to $36 for the quarter ended December 31, 2011, compared to $40 for the same period in the prior year. We are also pleased to report that our online sales increased by 19% to $38.7 million for the quarter, compared to $32.4 million for the same quarter the prior year, with approximately 77% of our orders being generated from our website during the quarter, compared to 72% in the same quarter in the prior year. Our reorder sales increased by 8% to $40.5 million for the quarter compared to $37.3 million for the same quarter the prior year. During the quarter, the Company leveraged its operating expenses as a percent of sales, by 92 basis points as compared to the same quarter in the prior year. Going forward, we will continue to advertise aggressively while expanding our product offerings, which include generic pet medications."

[R-BgO]

PetMed Express will 15 US-Cents Dividende auszahlen

PetMed Express Inc. (ISIN: US7163821066, NYSE: PETS) wird seinen Aktionären eine unveränderte Quartalsdividende in Höhe von 15 US-Cents ausbezahlen. Erst im Januar wurde die Dividende um 20 Prozent auf 15 US-Cents vierteljährlich erhöht. Zuvor wurden 12,5 US-Cents ausgeschüttet. Amerikas größter Arzneimittelhändler für Tiere schüttet auf das Jahr gerechnet 0,60 US-Dollar an die Investoren aus. Damit beträgt die aktuelle Dividendenrendite beim derzeitigen Börsenkurs von 11,07US-Dollar 5,42 Prozent. Im Jahr 2009 verkündete der Konzern die erstmalige Zahlung einer Dividende.

PetMed hat seinen Konzernsitz in Florida und vertreibt über Internet, Telefon oder Fax Medikamente, Futter, Pflegeprodukte und Spielsachen für Hunde, Katzen und Pferde. Gegründet wurde das Unternehmen im Jahr 1996. Gestern gab der Konzern seine Geschäftszahlen bekannt. Im Jahr 2011 kletterte der Umsatz von 231,6 Mio. US-Dollar im Vorjahr auf nun 238,3 Mio. US-Dollar. Der Gewinn betrug 16,7 Mio. US-Dollar bzw. 0,80 US-Dollar je Aktie nach 20,9 Mio. US-Dollar bzw. 0,92 US-Dollar je Aktie im Vorjahr. An der Börse kamen die Zahlen nicht gut an, zum Börsenschluss lag der Aktienkurs knapp 20 Prozent im Minus.

Redaktion MyDividends.de

[R-BgO]

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES A SPECIAL DIVIDEND

Pompano Beach, Florida, December 3, 2012 - PetMed Express, Inc. (NASDAQ: PETS) today announced that its Board of Directors declared a special dividend of $1.00 per share on its common stock. The dividend will be payable on December 24, 2012, to shareholders of record at the close of business on December 14, 2012. The Company intends to continue to pay regular quarterly dividends; however the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.

[R-BgO]

dehistorize

[R-BgO]

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES

ITS SECOND QUARTER FINANCIAL RESULTS AND ITS $0.18 PER SHARE QUARTERLY DIVIDEND

Second Quarter Net Income Increased 18%

Pompano Beach, Florida, October 19, 2015 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended September 30, 2015. Excluding a one-time charge for an IT-related discontinued project in the quarter and six months ended September 30, 2014, net income for the quarter ended September 30, 2015 was $4.5 million, or $0.22 diluted per share, compared to net income of $3.8 million, or $0.19 diluted per share, for the quarter ended September 30, 2014, an 18% increase to net income, and net income for the six months ended September 30, 2015 was $10.3 million, or $0.51 diluted per share, compared to net income of $8.8 million, or $0.44 diluted per share, for the six months ended September 30, 2014, a 17% increase to net income. This one-time IT-related discontinued project cost of $1.7 million was expensed in the quarter ended September 30, 2014. The after tax net impact of this charge was $1.1 million, or $0.05 diluted per share. Net sales for the quarter ended September 30, 2015 were $56.7 million, compared to $57.6 million for the quarter ended September 30, 2014, a decrease of 1.5%. Net sales for the six months ended September 30, 2015 were $128.4 million, compared to $130.1 million for the six months ended September 30, 2014, a decrease of 1.4%. The Company’s online sales for the quarter ended September 30, 2015 were approximately 81% of all sales, compared to 80% for the same quarter the prior year.

Menderes Akdag, CEO and President, commented: "Despite sales being down slightly we were able to increase both gross profit margins and average order size during the quarter. For the quarter ended September 30, 2015 our gross profit increased 128 basis points, which can be attributed to a shift in sales to higher margin items. Our average order size increased to $80 for the quarter ended September 30, 2015, compared to $75 for the same quarter in the prior year. Excluding the one-time charge in the quarter ended September 30, 2014, for the quarter ended September 30, 2015 our operating expenses decreased by about 79 basis points, which can be attributed to a reduction in advertising spending. For the remainder of Fiscal 2016 we are focusing on improving our marketing efforts to increase sales and profitability."

The Board of Directors declared a quarterly dividend of $0.18 per share on the Company’s common stock. The dividend will be payable on November 13, 2015, to shareholders of record at the close of business on November 2, 2015. The Company intends to continue to pay regular quarterly dividends; however the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.

[R-BgO]

Antwort auf Beitrag Nr.: 50.887.620 von R-BgO am 20.10.15 12:27:24

GJ 2015-2016

ging mal wieder besser aus

[R-BgO]

gestern +25% wegen 4% mehr gross margin...

[Scheich2000]

heute geht es weiter aufwärts...endlich. frage mich warum so wenige leute hier im forum aktiv sind.

[Scheich2000]

hoffe wir sehen endlich kurse von über 35 usd...das wäre ein traum und dann bitte schnell weiter richtung 40 usd.

[Scheich2000]

endlich die 40 usd genommen. bitte weiter so.

[R-BgO]

die letzten 2 Jahre war echt Leben in der Bude

[R-BgO]

Antwort auf Beitrag Nr.: 57.894.912 von R-BgO am 02.06.18 23:08:20

hmmmmm...:

http://aureliusvalue.com/research/petmed-exploiting-americas…

[Fullhouse1]

So eine Anfangsposition gekauft. Der Boden dürfte erreicht sein. Für mich sieht die Firma interessant aus . Habe sie aus der US Div Champ Liste rausgefiltert